399 related articles for article (PubMed ID: 30691479)
1. Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer's disease.
Adav SS; Park JE; Sze SK
Mol Brain; 2019 Jan; 12(1):8. PubMed ID: 30691479
[TBL] [Abstract][Full Text] [Related]
2. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.
Völgyi K; Badics K; Sialana FJ; Gulyássy P; Udvari EB; Kis V; Drahos L; Lubec G; Kékesi KA; Juhász G
Mol Neurobiol; 2018 Oct; 55(10):7839-7857. PubMed ID: 29468564
[TBL] [Abstract][Full Text] [Related]
3. Proteomic alterations of brain subcellular organelles caused by low-dose copper exposure: implication for Alzheimer's disease.
Yu H; Wang D; Zou L; Zhang Z; Xu H; Zhu F; Ren X; Xu B; Yuan J; Liu J; Spencer PS; Yang X
Arch Toxicol; 2018 Apr; 92(4):1363-1382. PubMed ID: 29383422
[TBL] [Abstract][Full Text] [Related]
4. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.
Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M
Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390
[TBL] [Abstract][Full Text] [Related]
5. Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease.
Chou JL; Shenoy DV; Thomas N; Choudhary PK; Laferla FM; Goodman SR; Breen GA
J Proteomics; 2011 Apr; 74(4):466-79. PubMed ID: 21237293
[TBL] [Abstract][Full Text] [Related]
6. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.
Zelaya MV; Pérez-Valderrama E; de Morentin XM; Tuñon T; Ferrer I; Luquin MR; Fernandez-Irigoyen J; Santamaría E
Oncotarget; 2015 Nov; 6(37):39437-56. PubMed ID: 26517091
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Repair Effects of Oxygen Treatment on Alzheimer's Disease Model Mice Revealed by Quantitative Proteomics.
Wang H; Hong X; Wang Y
J Alzheimers Dis; 2017; 56(3):875-883. PubMed ID: 28059791
[TBL] [Abstract][Full Text] [Related]
8. Effects of DISC1 on Alzheimer's disease cell models assessed by iTRAQ proteomics analysis.
Lu J; Huang R; Peng Y; Wang H; Feng Z; Fan Y; Zeng Z; Wang Y; Wei J; Wang Z
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34981809
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Dysfunction as a Predictor and Driver of Alzheimer's Disease-Like Pathology in OXYS Rats.
Tyumentsev MA; Stefanova NA; Muraleva NA; Rumyantseva YV; Kiseleva E; Vavilin VA; Kolosova NG
J Alzheimers Dis; 2018; 63(3):1075-1088. PubMed ID: 29710722
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease.
Gallart-Palau X; Lee BS; Adav SS; Qian J; Serra A; Park JE; Lai MK; Chen CP; Kalaria RN; Sze SK
Mol Brain; 2016 Mar; 9():27. PubMed ID: 26983404
[TBL] [Abstract][Full Text] [Related]
11. iTRAQ-based quantitative analysis of age-specific variations in salivary proteome of caries-susceptible individuals.
Wang K; Wang X; Zheng S; Niu Y; Zheng W; Qin X; Li Z; Luo J; Jiang W; Zhou X; Li W; Zhang L
J Transl Med; 2018 Oct; 16(1):293. PubMed ID: 30359274
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal characterization of the brain proteomes for the tg2576 amyloid mouse model using shotgun based mass spectrometry.
Shevchenko G; Wetterhall M; Bergquist J; Höglund K; Andersson LI; Kultima K
J Proteome Res; 2012 Dec; 11(12):6159-74. PubMed ID: 23050487
[TBL] [Abstract][Full Text] [Related]
13. Muscle biopsies from human muscle diseases with myopathic pathology reveal common alterations in mitochondrial function.
Sunitha B; Gayathri N; Kumar M; Keshava Prasad TS; Nalini A; Padmanabhan B; Srinivas Bharath MM
J Neurochem; 2016 Jul; 138(1):174-91. PubMed ID: 27015874
[TBL] [Abstract][Full Text] [Related]
14. Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis.
Zhan X; Li H; Qian S; Zhan X; Li N
J Vis Exp; 2019 Nov; (153):. PubMed ID: 31789316
[TBL] [Abstract][Full Text] [Related]
15. PTCD1 Is Required for Mitochondrial Oxidative-Phosphorylation: Possible Genetic Association with Alzheimer's Disease.
Fleck D; Phu L; Verschueren E; Hinkle T; Reichelt M; Bhangale T; Haley B; Wang Y; Graham R; Kirkpatrick DS; Sheng M; Bingol B
J Neurosci; 2019 Jun; 39(24):4636-4656. PubMed ID: 30948477
[TBL] [Abstract][Full Text] [Related]
16. A Set of Organelle-Localizable Reactive Molecules for Mitochondrial Chemical Proteomics in Living Cells and Brain Tissues.
Yasueda Y; Tamura T; Fujisawa A; Kuwata K; Tsukiji S; Kiyonaka S; Hamachi I
J Am Chem Soc; 2016 Jun; 138(24):7592-602. PubMed ID: 27228550
[TBL] [Abstract][Full Text] [Related]
17. Quantitative clinical proteomic study of autopsied human infarcted brain specimens to elucidate the deregulated pathways in ischemic stroke pathology.
Datta A; Akatsu H; Heese K; Sze SK
J Proteomics; 2013 Oct; 91():556-68. PubMed ID: 24007662
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease.
Cadonic C; Sabbir MG; Albensi BC
Mol Neurobiol; 2016 Nov; 53(9):6078-6090. PubMed ID: 26537901
[TBL] [Abstract][Full Text] [Related]
19. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
[TBL] [Abstract][Full Text] [Related]
20. Duplexing complexome profiling with SILAC to study human respiratory chain assembly defects.
Páleníková P; Harbour ME; Prodi F; Minczuk M; Zeviani M; Ghelli A; Fernández-Vizarra E
Biochim Biophys Acta Bioenerg; 2021 Jun; 1862(6):148395. PubMed ID: 33600785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
